Immunomodulatory drug maintenance therapy vs placebo/observation
Treatment‐related mortality · people with chronic lymphocytic leukaemia
Immunomodulatory drug maintenance therapy showed no clear difference in treatment‐related mortality compared with placebo/observation (low certainty).
1 finding from 1 review
- Risk ratio 1.22 [0.35, 4.29]3 studies · 458 participantsLow